Strasbourg Translational Neuroscience & Psychiatry - UMR_S 1329 - CRBS - Centre de recherche en biomédecine de Strasbourg - Université de Strasbourg https://crbs.unistra.fr fr Strasbourg Translational Neuroscience & Psychiatry - UMR_S 1329 - CRBS - Centre de recherche en biomédecine de Strasbourg - Université de Strasbourg Thu, 21 Nov 2024 13:35:35 +0100 Thu, 21 Nov 2024 13:35:35 +0100 TYPO3 EXT:news news-17078 Mon, 14 Oct 2024 17:17:00 +0200 Foundation for Medical Research Prize /en/news/news/foundation-for-medical-research-prize Caroline Rouaux, winner of the Fabrice Le Mouhaër Prize from the French Foundation for Medical Research On October 14, 2024, the Fabrice Le Mouhaër Prize of the French Foundation for Medical Research was awarded to Caroline Rouaux, head of the ALS/FTD team.

The €40,000 prize is intended to fund research into Amyotrophic Lateral Sclerosis.

Caroline Rouaux and her team have identified an atypical brainwave profile in patients, associated with noradrenaline deficiency. This discovery could pave the way for early diagnosis, and could be a clue to future treatment.

 

Discover all the 2024 winners of the French Foundation Foundation for Medical Research on their website (in french).

]]>
Actualités STEP
news-16731 Fri, 05 Jul 2024 11:22:53 +0200 Doctoral grants and 4th-year thesis funding /en/news/news/subventions-doctorales-et-financement-de-4eme-annee-de-these Dersu OZDEMIR, a PhD student in her 4th year, and Solène POIVEY, a future PhD student, have both obtained funding to continue their work in the Addictions team. Dersu is interested in the role of habenular mu-opioid receptor expressing neurons in negative affect in a naïve and opioid-dependent state. She recently received a grant from the Fondation pour la Recherche Médicale (FRM) to finance the fourth year of her thesis and continue her work on the habenula.

As for Solène, she responded to a call for applications from the Institut pour la Recherche en Santé Publique (IReSP) and the Institut National du Cancer (INCa) for a doctoral grant, which she was awarded. We are therefore delighted to announce that she will be joining us in October to begin her thesis on the role of opiate-sensitive neurons in the control of hedonic mechanisms and food intake.

]]>
Actualités STEP
news-16699 Wed, 26 Jun 2024 11:50:48 +0200 A new step in characterizing the emotional consequences of opioid withdrawal /en/news/news/un-nouveau-pas-dans-la-caracterisation-des-consequences-emotionnelles-du-sevrage-aux-opiaces The University of Strasbourg's Savoir(s) newspaper spotlights the Addictions team!

https://savoirs.unistra.fr/innovation/un-nouveau-pas-dans-la-caracterisation-des-consequences-emotionnelles-du-sevrage-aux-opiaces

]]>
Actualités STEP
news-16673 Thu, 13 Jun 2024 14:00:00 +0200 Ice Bucket Challenge against ALS 2024 /en/news/news/ice-bucket-challenge-als-2024  

10 years after the viral phenomenon of the Ice Bucket Challenge, designed to raise media awareness and funds for the fight against Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig’s disease (known in France as Charcot's disease), the challenge is back in France, on the initiative of Les Invincibles led by Olivier Goy and the Association pour la Recherche sur la SLA (ARSLA). The Défi Givré 2024 is being passed on among well-known media and social network personalities, as well as in the ALS research community.

 

After Dr Séverine Boillée's team at the Institut du Cerveau in Paris, Dr Caroline Rouaux's team at the Centre de Recherche en Biomédecine in Strasbourg took up the challenge on Thursday June 13, challenging in turn Dr Cédric Raoul's team at the Institut des Neurosciences in Montpellier, as well as influencer Hugo Décrypte and comedian and humorist Nicole Ferroni.

 

Donations collected via https://www.defigivre.org, are dedicated to accelerating ALS research.

 

]]>
Actualités STEP
news-16544 Wed, 15 May 2024 14:00:00 +0200 Model of negative affect induced by withdrawal after acute and chronic administration of morphine /en/news/news/withdrawal-upon-moprhine-administration The mechanisms behind negative affect following opiate withdrawal precipitated by an antagonist such as naloxone are not well known. The Addictions team has therefore been looking into this issue, and recent work by Dersu OZDEMIR has enabled us to compare three different conditions.  

The study investigated three patterns of negative affect due to precipitated naloxone withdrawal:

  • Withdrawal following acute morphine treatment
  • Withdrawal following constant chronic morphine treatment
  • Withdrawal following increasing chronic morphine treatment

The team demonstrated that chronic morphine treatment was necessary to observe a deficit in social interaction and desper-like behaviour. In addition, all three models induced anxiety-like behaviour.

Overall, these models will contribute to the study of the behavioural and neural circuits involved in the various negative affective signs characterising opioid use disorders.

 

Source:  Ozdemir D. et al. Model of negative affect induced by withdrawal from acute and chronic morphine administration in male miceScientific Reports 14, (2024). https://doi.org/10.1038/s41598-024-60759-3

Contact: Emmanuel Darcq, edarcq[at]unistra.fr

 

]]>
Actualités STEP Publications STEP
news-16438 Fri, 12 Apr 2024 14:00:00 +0200 INSERM NeuroTechnologies /en/news/news/inserm-neurotechnologies INSERM's NeuroTechnologies impulse programme was officially launched on 12 April 2024! The "Probing & Modulating the Brain Activity" project will enable the team to develop stimulation projects targeting the cerebellum on the CEMNIS platform, with new collaborations (Charalambos Papaxanthis, Charlotte Rosso, Marion Plaze, Jean-François Aubry).

 

]]>
Actualités STEP
news-16440 Fri, 12 Apr 2024 14:00:00 +0200 Thesis Award: Psychiatry team /en/news/news/thesis-award-psychiatry-team Does a multidimensional conception of apathy allow us to better understand its mechanisms ? : cognitive and electrophysiological approach Actualités STEP news-16468 Fri, 12 Apr 2024 14:00:00 +0200 Attention-Deficit/Hyperactivity Disorder (ADHD) /en/news/news/information-adhd Attention-Deficit/Hyperactivity Disorder (ADHD): Strasbourg is one of the leading cities in its detection and treatment!

 

]]>
Actualités STEP
news-15587 Mon, 01 Jan 2024 14:00:00 +0100 Formal establishment of the INSERM UMR-S 1329 unit /en/news/news/inserm-umr-s-1329 INSERM unit UMR-S 1329, the result of the merger of ex-UMR-S 1114 & 1118, officially takes office on January 1st, 2024. This new INSERM multi-team is headed by Luc Dupuis and co-directed by Anne Giersch (Pychiatry team), Laurence Lalanne & Emmanuel Darcq (Addictions team) and Caroline Rouaux (ALS-FTD team).

]]>
Actualités STEP
news-15440 Fri, 14 Apr 2023 14:00:00 +0200 Hypothalamic hormone linked to metabolic dysregulation in ALS /en/news/news/hypothalamic-hormone-dysregulation-in-als This recent research shows that the loss of MCH+ hypothalamic neurons is linked to the metabolic problems that occur in ALS. Amyotrophic lateral sclerosis (ALS), also known as Charcot's disease, is a disease of the motor neurons (motoneurons), the nerve cells that control our muscles, and is the most common disease in adults.

The work of Matei Bolborea, a researcher in the unit, has shown that the loss of MCH+ hypothalamic neurons is linked to the metabolic problems that occur in ALS. The results have just been published in the journal Acta Neuropathologica.

The study shows that when these MCH+ neurons are no longer present in the hypothalamus, numerous metabolic problems arise, and that this neurodegeneration is coupled with TDP-43 aggregates in these same neurons.

In addition to this analysis, MCH supplementation helped to restore the metabolic deficits observed (weight loss, low food intake).

Thanks to numerous international collaborations (Ulm University, Germany; Leuven Brain Institute, Belgium; Chiba University School of Medicine, Japan), the team was able to show that the loss of MCH+ hypothalamic neurons was linked to the metabolic deficits in ALS.

This new lead opens up horizons for potential new research and therapeutic avenues. This hypothalamic neurodegeneration in ALS could explain the metabolic deficits already reported in numerous other studies.

All in all, this study shows several direct links between metabolic deficits and central neurodegeneration in ALS.

 

Source:  Bolborea M., et al. Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis. Acta Neuropathol 145, 773–791 (2023). https://doi.org/10.1007/s00401-023-02569-x

Contact: Luc Dupuis, ldupuis[at]unistra.fr; Matei Bolborea mbolborea[at]unistra.fr

 

Credits: Simon J. Guillot

]]>
Actualités STEP Publications STEP
news-13273 Thu, 23 Mar 2023 15:52:18 +0100 Establishment of an ALS patient cohort /en/news/news/establishment-als-patient-cohort The FG-COALS project - Franco-German cohort study on factors associated with weight loss in ALS - led by Luc Dupuis (CRBS - INSERM Unit 1118) and Philippe Couratier (CHU Limoges) has been awarded €1.3M in funding from the Programme investissements d'avenir (PIA 3).

 

The FG-COALS project - French-German cohort study on factors associated with weight loss in ALS* - led by Luc Dupuis (CRBS - INSERM Unit 1118) and Philippe Couratier (CHU Limoges) has been awarded €1.3M in funding from the Programme Investissements d'avenir (PIA 3).

This project will enable the establishment of a French-German cohort of 2,000 ALS patients.

The aim is to provide a better understanding of the natural history of the disease, the genetic basis of its symptoms and to understand the factors associated with massive weight loss during the course of the disease.

The unit contributes mainly to the genetic aspects of this project and to the study of weight loss factors.

-----
* French-German cohort study to determine the factors associated with weight loss in amyotrophic lateral sclerosis: pathophysiological significance and resulting therapeutic targets

More about FG-COALS project

 

Credits: Simon J. Guillot

 

]]>
Actualités STEP
news-13127 Wed, 15 Mar 2023 14:00:00 +0100 New genes linked to ALS /en/news/news/new-genes-linked-to-als Work by Luc Dupuis' team has shown direct links between the genetics and anatomopathology of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). ALS is a disease of the motor neurons (motor neurons), the nerve cells that control our muscles, and is the most common disease in adults.

Work of Salim Megat, a team member, has led to a better understanding of the genetic structure of ALS, which findings have just been published in Nature Communications.

The study shows that new genetic risk factors for ALS are present in certain parts of the genome that are important for specific proteins, notably TDP-43 and FUS. While these proteins accumulate abnormally in the brain of patients. Beyond this analysis, several new genes associated with ALS have been identified.

Thanks to numerous national (Institut du Cerveau, Paris; CHU de Limoges, Institut Imagine) and international (DZNE Ulm, Germany; Donders Institute, Nijmegen, Netherlands) collaborations, the team was able to show that the loss of function of one of these genes, NUP50, was associated with ALS.

NUP50 is a nuclear pore protein, which allows the trafficking of proteins between the cell nucleus and the cytoplasm. Its loss in ALS could explain the significant nuclear pore abnormalities already observed in many other studies.

As a whole, this study establishes several novel direct links between the genetics and pathophysiology of ALS.

 

Source :  Megat S., et al. Integrative genetic analysis illuminates ALS heritability and identifies risk genes. Nat Commun 14, 342 (2023). https://doi.org/10.1038/s41467-022-35724-1

Contact: Luc Dupuis, ldupuis[at]unistra.fr

 

Credits: Helene Cheung-Bouaoun

]]>
Actualités STEP Publications STEP
news-15437 Mon, 26 Sep 2022 09:00:00 +0200 New illusion /en/news/news/new-illusion The team has developed a new illusion that allows us to explore sensory predictions that we don't even know exist. The regularities of the environment make it possible to predict future information and to adapt in the event of irregularity or prediction error. However, little is known about how these errors influence conscious perception, especially when the predictions concern elementary visual features (orientation, contrast, edges: the assembly of these features enables object recognition). We have therefore developed a new experimental approach using moving objects to study the perceptual consequences of prediction errors on elementary visual features.

Two squares move towards each other. The participants indicated whether or not they were in contact before they disappeared. When two objects move towards each other, we expect them to meet. However, this is not what the participants in our study reported. A strong illusion of a large gap between the squares occurs when the edges of the squares briefly touch.

We have carried out several experimental studies with healthy volunteers, and the results consistently suggest that the origin of the effects lies in the initial visual processing of the basic features of the squares. The results rule out an explanation in terms of decision bias, attentional effects or masking. We propose an explanation in the context of 'predictive coding'; violations of the extrapolation of the figure-ground contrast have strong perceptual consequences, as if the subject saw his or her prediction (although not consciously) about the figure-ground contrast, rather than the disappearance of the contrast on contact.

This new illusion constitutes a tool for exploring the mechanisms of elementary visual prediction in autism and schizophrenia in our laboratory.

 

Read more about illusions: https://doi.org/10.1016/j.cognition.2022.105279

Read more about 'predictive coding': https://doi.org/10.1002/wcs.142

Read more about psychiatric disorders:

doi.org/10.1016/j.biopsych.2018.05.015

 

Credits: Estelle Koning

]]>
Actualités STEP
news-15452 Thu, 24 Jun 2021 12:20:00 +0200 ALS-FTD team /en/als-ftd/presentation#c64840 Focus STEP news-15451 Thu, 24 Jun 2021 12:20:00 +0200 Addiction team /en/addictions Focus STEP news-15450 Thu, 24 Jun 2021 12:20:00 +0200 Psychiatry team /en/psychiatry Focus STEP